In a randomized, double-blind, placebo-controlled crossover trial of 30 adults with obesity (Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity, Blundell and colleagues, Diabetes, Obesity and Metabolism , 2017), 12 weeks of once-weekly semaglutide titrated to 1.0 mg was associated with less hunger, fewer food cravings, better control of eating, and a lower preference for high-fat foods
The sheer number of compounds in development means that within five years, the weight management medication landscape will look dramatically different than it does today
A few signs of a correctly administered injection include feeling little to no discomfort while injecting, no leakage of medication back out of the skin, and minimal blood or fluid at the injection site
Weeks 5 to 8: Portions shrink without feeling deprived